SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001567619-17-001374
Filing Date
2017-07-06
Accepted
2017-07-06 06:45:20
Documents
3
Period of Report
2017-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s001773x1_8k.htm 8-K 29527
2 EXHIBIT 99.1 s001773x1_ex99-1.htm EX-99.1 10200
3 s001773x1_ex99-1logo.jpg GRAPHIC 4821
  Complete submission text file 0001567619-17-001374.txt   47682
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 17950800
SIC: 2834 Pharmaceutical Preparations